Cardiology/Electrophysiology University Hospital Basel University Basel Basel Switzerland.
Cardiovascular Research Institute Basel University Hospital Basel University Basel Basel Switzerland.
J Am Heart Assoc. 2020 Mar 3;9(5):e014446. doi: 10.1161/JAHA.119.014446. Epub 2020 Feb 22.
Background Left bundle branch block (LBBB) is common after transcatheter aortic valve implantation (TAVI) and is an indicator of subsequent high-grade atrioventricular block (HAVB). No standardized protocol is available to identify LBBB patients at risk for HAVB. The aim of the current study was to evaluate the safety and efficacy of an electrophysiology study tailored strategy in patients with LBBB after TAVI. Methods and Results We prospectively analyzed consecutive patients with LBBB after TAVI. An electrophysiology study was performed to measure the HV-interval the day following TAVI. In patients with normal His-ventricular (HV)-interval ≤55 ms, a loop recorder was implanted (ILR-group), whereas pacemaker implantation was performed in patients with prolonged HV-interval >55 ms (PM-group). The primary end point was occurrence of HAVB during a follow-up of 12 months. Secondary end points were symptoms, hospitalizations, adverse events because of device implantation or electrophysiology study, and death. Of 373 patients screened after TAVI, 56 patients (82±6 years, 41% male) with LBBB were included. HAVB occurred in 4 of 41 patients (10%) in the ILR-group and in 8 of 15 patients (53%) in the PM-group (<0.001). We did not identify other predictors for HAVB than the HV interval. The negative predictive value for the cut-off of HV 55 ms to detect HAVB was 90%. No HAVB-related syncope occurred in the 2 groups. Conclusions An electrophysiology study tailored strategy to LBBB after TAVI with a cut-off of HV >55 ms is a feasible and safe approach to stratify patients with regard to developing HAVB during a follow-up of 12 months.
经导管主动脉瓣植入术(TAVI)后常发生左束支传导阻滞(LBBB),是发生后续高度房室传导阻滞(HAVB)的指标。目前尚无确定 LBBB 患者发生 HAVB 风险的标准化方案。本研究旨在评估 TAVI 后 LBBB 患者行电生理研究定制策略的安全性和有效性。
我们前瞻性分析了 TAVI 后发生 LBBB 的连续患者。在 TAVI 后第 1 天进行电生理研究以测量 HV 间期。在 HV 间期正常(≤55ms)的患者中植入环路记录仪(ILR 组),而 HV 间期延长(>55ms)的患者植入起搏器(PM 组)。主要终点是 12 个月随访期间发生 HAVB。次要终点是症状、住院、因设备植入或电生理研究导致的不良事件以及死亡。在 TAVI 后筛选的 373 例患者中,有 56 例(82±6 岁,41%为男性)患者发生 LBBB。ILR 组中有 4 例(10%)患者发生 HAVB,PM 组中有 8 例(53%)患者发生 HAVB(<0.001)。除 HV 间期外,我们未发现其他预测 HAVB 的因素。HV 55ms 切点预测 HAVB 的阴性预测值为 90%。2 组均未发生与 HAVB 相关的晕厥。
对于 TAVI 后 LBBB,以 HV>55ms 为切点行电生理研究定制策略是一种可行且安全的方法,可在 12 个月的随访期间分层患者发生 HAVB 的风险。